Chlorpromazine Induced Cataract in a female patient: A Case Report

Authors

  • Nidhi Rajeshwori Thapa Department of Psychiatry, Nepal Medical College and Teaching Hospital, Kathmandu, Nepal
  • Deepika Karki Nepal Medical College and Teaching Hospital, Kathmandu, Nepal
  • Asim Shrestha Nepal Medical College and Teaching Hospital, Kathmandu, Nepal
  • Pradip Man Singh Department of Psychiatry, Nepal Medical College and Teaching Hospital, Kathmandu, Nepal

DOI:

https://doi.org/10.3126/jpan.v11i2.57688

Keywords:

cataract, chlorpromazine, schizophrenia, antipsychotic agents

Abstract

Tablet Chlorpromazine is a commonly used, affordable antipsychotic in developing countries. Chlorpromazine induced cataract and corneal pigmentation was first described by Greiner & Berry in 1964 but in the context of Nepal, there is no available literature or cases reported to date. Despite having a myriad of side effects, it is still used frequently in developing countries due to its cost-effectiveness. In this light, we report a case of a 43-year-old female with a diagnosis of Schizophrenia who had been treated with Tab. Chlorpromazine for 25 years. She lost to follow-up and presented at the OPD with cataract in bilateral eyes.  

Downloads

Download data is not yet available.
Abstract
41
PDF
67

Downloads

Published

2022-12-31

How to Cite

Thapa, N. R., Karki, D., Shrestha, A., & Singh, P. M. (2022). Chlorpromazine Induced Cataract in a female patient: A Case Report. Journal of Psychiatrists' Association of Nepal, 11(2), 49–51. https://doi.org/10.3126/jpan.v11i2.57688

Issue

Section

Case Report